Phio Pharmaceuticals Corp.
PHIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533040
In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Phio Pharmaceuticals Corp. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 11 | 11 | 0 |
| Shares | 154.0K | 100.6K | −53.4K (−34.7%) |
| Value | $277.4K | $130.8K | −$146.6K (−52.9%) |
New holders (3)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 41,586 | $54.1K | 0.00% |
| XTX Topco Ltd | 10,800 | $14.0K | 0.00% |
| Assetmark, Inc | 110 | $143 | 0.00% |
Sold out (3)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 44,526 | $80.1K |
| HRT Financial LP | 42,338 | $76.0K |
| Virtu Financial LLC | 40,910 | $74.0K |